Argolyn Bioscience

Developer of peptide-based drug candidates

placeDurham, North Carolina, United States calendar_todayFounded 2002 language argolyn.com

Registered entities

Innovation

2 patent families — focus: Chemistry & metallurgy; filing pace dormant. Cited 7 times.

Investor mix

3 investors on record; lead investors include Intersouth Partners, Quaker Partners.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%
Coming soon